Anew Labs raises $290M Series A

Anew Labs is an AI drug discovery company that combines generative models with experimental science. The company announced a $290M Series A on September 16, 2026, from its base in Shanghai, CN. Investors and valuation were not disclosed in Crunchbase's round record; Lounge adds them as they are reported. It has raised more than $100M in total venture funding.